Cureverse: Funding, Investors & Team (Oct 2026)
Galaxy operates a pharmaceutical research and development company for the treatment of encephalopathy and oncology diseases. The company focuses on creating remedies for challenging brain conditions like dementia, thereby assisting healthcare professionals in enhancing human well-being and overall quality of life.
Cureverse has raised $990k across 1 funding round on record, the most recent an undisclosed round of $990k announced in May 2026.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Cureverse Company Profile and Key Stats
Latest funding round on record: May 2026.
Cureverse Funding Rounds
Cureverse Founders and Leadership Team
Contact details for the Cureverse team: 1 has a LinkedIn profile.
Start 14-day free trial →Cureverse Funding Compared to Other Biotechnology Startups
Cureverse's latest round of $990k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Cureverse in Biotechnology and Seoul
Companies Similar to Cureverse
ArcGen Bioscience is a biopharmaceutical development company
Lego Chem Bioscience , a company created by people with dreams and enthusiasm for global new drug…
April Bio is a drug development company that develops antibodies and long-acting biologics.
The company is a spin-off from Asan Medical Center, University of Ulsan University, with a primary objective…
LabGenomics is a healthcare company specialized in molecular diagnostics.
SPARK BioPharma Co., Ltd. was established in Seoul National University in January 2016 based on the unique…
3billion was founded with the goal of ending the diagnostic odyssey of rare disease patients through…
Shaperon is a clinical-stage biotech company that develops inflammasome inhibitors.
SN BioScience provide nano-formulation screening services for small molecule, oligonucleotide (siRNA, DNA),…
M-Based develops new alternative material technologies using mushrooms. 🍄 We consider environmental…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Turning biomass residues into fit-for-purpose microbial fertilizers, biostimulants and biocontrols.
Cureverse Funding FAQs
What does Cureverse do?
Galaxy operates a pharmaceutical research and development company for the treatment of encephalopathy and oncology diseases. The company focuses on creating remedies for challenging brain conditions like dementia, thereby assisting healthcare professionals in enhancing human well-being and overall quality of life.
How much funding has Cureverse raised?
Cureverse has raised $990k across 1 round on record. The most recent is an undisclosed round of $990k announced in May 2026.
When did Cureverse last raise funding?
Cureverse's most recent funding round on record is an undisclosed round of $990k, announced in May 2026.
Who founded Cureverse?
FundedIQ lists Jungwook Chin (Founder) at Cureverse.
Where is Cureverse headquartered?
Cureverse is based in Seoul, Seoul-t'ukpyolsi, South Korea.
How many employees does Cureverse have?
Cureverse is in the 1-10 employee band.
How does Cureverse's funding compare to other Biotechnology startups?
Cureverse's latest round of $990k is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Cureverse Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Cureverse is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.